Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis.

Neoadjuvant vs perioperative chemo-immunotherapy according to pathological response in resectable non-small cell lung cancer: a reconstructed individual patient data meta-analysis. J Natl Cancer Inst. 2025 Nov 01; 117(11):2388-2393.

View in: PubMed

subject areas

Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Non-Small-Cell Lung
Chemotherapy, Adjuvant
Humans
Immunotherapy
Lung Neoplasms
Neoadjuvant Therapy
Perioperative Care
Prognosis
Survival Analysis
Treatment Outcome

authors with profiles

Marina Chiara Garassino